From: Infectious disease testing of UK-bound refugees: a population-based, cross-sectional study
Country of nationality | Number screened (n) | Number of cases detected | Yield in tested cohort, % (95% CI)a | Estimated prevalence of chronic HBV infection (HBsAg seroprevalence), 1965–2013, % (95% CI) [21] |
---|---|---|---|---|
Afghanistan | 57 | 1 | 1.75 (0.24–11.61) | 1.62 (1.29–2.03) |
Democratic Republic of Congo | 499 | 29 | 5.81 (4.07–8.24) | 5.99 (5.68–6.31) |
Eritrea | 54 | 0 | 0.0 | 2.49 (2.32–2.67) |
Ethiopia | 251 | 12 | 4.78 (2.73–8.24) | 6.03 (5.77–6.31) |
Iran | 14 | 0 | 0.0 | 0.96 (0.95–0.96) |
Iraq | 514 | 3 | 0.58 (0.19–1.79) | 0.67 (0.65–0.70) |
Palestine | 28 | 0 | 0.0 | 1.80 (1.07–3.02) |
Somalia | 384 | 13 | 3.39 (1.97–5.75) | 14.77 (13.77–15.84) |
South Sudan | 40 | 5 | 12.50 (5.24–26.96) | 22.38 (20.10–24.84) |
Sudan | 361 | 21 | 5.82 (3.82–8.76) | 9.76 (9.03–10.54) |
Syria | 6996 | 102 | 1.46 (1.20–1.77) | 2.62 (2.17–3.17) |
Uganda | 2 | 0 | 0.0 | 9.19 (8.65–9.77) |
Other AFRb | 8 | 1 | 12.50 (1.50–57.31) | 8.83 (8.82–8.83) |
Other EMRc | 9 | 0 | 0.0 | 3.01 (3.01–3.01) |
Other EURd | 5 | 1 | 20.00 (2.11–74.35) | 2.06 (2.06–2.06) |
Other WPRe | 3 | 0 |  | 5.26 (5.26–5.26) |
Total | 9228 | 188 | 2.04 (1.77–2.35) |  |